COMMUNIQUÉS West-GlobeNewswire

Transactions in relation to share buyback program
24/07/2018
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
ViroGates Releases Second Quarter 2018 Financial Results
24/07/2018
Company announcement no. 4-2018 Birkerød, 24 July 2018 ViroGates Releases Second Quarter 2018 Financial Results ViroGates A/S (Nasdaq First North Denmark: VIRO), who delivers blood test systems for the Emergency [...]
Sensorion Initiates Safety Study of Seliforant Versus Meclizine In Evoked Vestibular Imbalance
24/07/2018
Safety and pharmacodynamic effects of seliforant compared to meclizine MONTPELLIER, France, July 24, 2018 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468 – ALSEN), a biotech company specializing in the treatment of inner [...]
Idorsia announces financial results for the first half 2018
24/07/2018
Allschwil, Switzerland - July 24, 2018 Idorsia Ltd (SIX: IDIA) today announced its financial results for the first half of 2018. Jean-Paul Clozel, MD and Chief Executive Officer, commented: "We have made significant [...]
AC Immune Announces Closing of First Subscription Rights Offering and Primary Offering as well as Full Exercise of Option to Purchase Additional Shares
24/07/2018
Lausanne, Switzerland, July 24, 2018 - AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company focused on neurodegenerative diseases, today announced the closing of its previously announced [...]
UPDATE - Lexicon Pharmaceuticals to Host Second Quarter 2018 Financial Results Conference Call and Webcast on July 30, 2018
23/07/2018
THE WOODLANDS, Texas, July 23, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq:LXRX), will release its second quarter 2018 financial results on Monday, July 30, 2018 before market opens. Management will [...]
Ascendis Pharma A/S Announces Poster Presentation on TransCon Technology at the Controlled Release Society Annual Meeting
23/07/2018
COPENHAGEN, Denmark, July 23, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs, today [...]
Radius Health to Announce Second Quarter 2018 Financial Results, Host Conference Call and Live Webcast on August 7, 2018
23/07/2018
WALTHAM, Mass., July 23, 2018 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq:RDUS) announced today that it will release its second quarter financial results on Tuesday, August 7, 2018. The Company will host a conference call [...]
Teladoc Announces Proposed Sale of Shares of Common Stock
23/07/2018
PURCHASE, NY, July 23, 2018 (GLOBE NEWSWIRE) -- Teladoc, Inc. (NYSE:TDOC) (“Teladoc”) today announced a proposed sale of shares of its common stock, which includes 5,000,000 shares offered by Teladoc and 263,740 shares [...]
Reata Pharmaceuticals, Inc. Announces Proposed Public Offering of Class A Common Stock
23/07/2018
IRVING, Texas, July 23, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq:RETA) (“Reata” or the “Company”), a clinical-stage biopharmaceutical company, today announced its intention to offer and sell 3,000, [...]
Vericel to Report Second-Quarter 2018 Financial Results on August 6, 2018
23/07/2018
CAMBRIDGE, Mass., July 23, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced the following webcast and [...]
Akcea Therapeutics to Hold Second Quarter 2018 Financial Results Webcast
23/07/2018
Webcast scheduled for Monday, August 6th at 4:30 p.m. Eastern Time CAMBRIDGE, Mass., July 23, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (Nasdaq:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., announced today [...]
Medigus Announces Closing of $10 Million Public Offering
23/07/2018
OMER, Israel, July 23, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (“Medigus” or the “Company”)(NASDAQ:MDGS) (TASE:MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct [...]
Establishment Labs Announces Closing of Initial Public Offering and Exercise in Full of Underwriters' Option to Purchase Additional Common Shares
23/07/2018
NEW YORK, July 23, 2018 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company focused on breast aesthetics and reconstruction technologies, today announced the closing [...]
Cara Therapeutics Announces Closing of Its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
23/07/2018
STAMFORD, Conn., July 23, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate [...]
TiGenix: Transparency notification pursuant to Article 14 of the Law of May 2, 2007
23/07/2018
REGULATED INFORMATION PRESS RELEASE Transparency notification pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - July 23, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix") [...]
Lexicon Pharmaceuticals to Host First Quarter 2018 Financial Results Conference Call and Webcast on July 30, 2018
23/07/2018
THE WOODLANDS, Texas, July 23, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq:LXRX), will release its second quarter 2018 financial results on Monday, July 30, 2018 before market opens. Management will [...]
Genesis HealthCare Expects to Release Second Quarter 2018 Results on August 7, 2018
23/07/2018
KENNETT SQUARE, Pa., July 23, 2018 (GLOBE NEWSWIRE) -- Genesis HealthCare (NYSE:GEN) (Genesis or the Company), one of the nation’s largest providers of post-acute care, today announced that it expects to release its [...]
Merit Medical Reports Record Revenues for Second Quarter of 2018; Merit Adjusts 2018 Guidance
23/07/2018
Q2 2018 worldwide revenue of $224.8 million ($221.2 million on a comparable, constant currency* basis), up 20.5% as reported (up 18.6% on a comparable, constant currency* basis) over Q2 2017 Q2 2018 core revenue* up 11. [...]

Pages